Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
Abstract Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from self or donors have their own advantages and disadvantages in their medical practice. Therapeutic benefits of u...
Guardado en:
Autores principales: | Chenghai Li, Hua Zhao, Linna Cheng, Bin Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9a0181604a0473094a7f3f403ffd713 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: E. V. Batorov, et al.
Publicado: (2012) -
Recent strategies for enhancing the therapeutic efficacy of stem cells in wound healing
por: Yongqing Zhao, et al.
Publicado: (2021) -
Microambiente medular en la leucemia mieloide crónica: su relación con la enfermedad y la respuesta al tratamiento
por: Aristizábal,José Alejandro, et al.
Publicado: (2014) -
MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
por: Faroogh Marofi, et al.
Publicado: (2021) -
Tumorigenic Aspects of MSC Senescence—Implication in Cancer Development and Therapy
por: Slavko Mojsilović, et al.
Publicado: (2021)